In-cell nMr spectroscopy is a unique tool for characterizing biological macromolecules in their physiological environment at atomic resolution. recent progress in nMr instruments and sample preparation methods allows functional processes, such as metal uptake, disulfide-bond formation and protein folding, to be analyzed by nMr in living, cultured human cells. this protocol describes the necessary steps to overexpress one or more proteins of interest inside human embryonic kidney 293t (HeK293t) cells, and it explains how to set up in-cell nMr experiments. the cDna is transiently transfected as a complex with a cationic polymer (Dna: peI (polyethylenimine)), and protein expression is carried on for 2-3 d, after which the nMr sample is prepared. 1 H and 1 H-15 n correlation nMr experiments (for example, using band-selective optimized flip-angle short-transient heteronuclear multiple quantum coherence (soFast-HMQc)) can be carried out in <2 h, ensuring cell viability. uniform 15 n labeling and amino-acid-specific (e.g., cysteine, methionine) labeling schemes are possible. the entire procedure takes 4 d from cell culture seeding to nMr data collection.
IntroDuctIon
In-cell NMR spectroscopy allows the study of biomolecules, in particular proteins, inside living cells. It is therefore a powerful method for acquiring structural and functional information about biomolecules at atomic resolution in their natural, physiological environment [1] [2] [3] [4] [5] . In-cell NMR has been used successfully on bacterial cells to analyze protein structure 6 , dynamics 7, 8 and interactions [9] [10] [11] . Although prokaryotic cells have some advantages, such as being easy to handle, growing fast and expressing exogenous proteins at high levels, in order for data on eukaryotic proteins to be meaningful, the proteins should be characterized in eukaryotic cells. Indeed, prokaryotic organisms exhibit a limited range of biological activities, and many of the cellular processes that define the challenging questions in biological research are absent in bacteria. Post-translational protein modifications regulate biological activities in eukaryotes, but they are much less common in prokaryotic organisms. The presence of organelles and the requirement of regulated cellular transport constitute other characteristics of eukaryotic cells. Compartmentalization causes the creation of subcellular environments with different physical and biological properties, and the effects that these compartments exert on the protein conformation, state and/or function need to be properly addressed.
To date, several approaches have been used to ensure that the proteins of interest are properly labeled and located inside the cytoplasm of eukaryotic cells. Microinjection, cell-penetrating peptides, pore-forming toxin and electroporation have been the most commonly used methods 3, 10, [12] [13] [14] . The large size of Xenopus laevis oocytes allows microinjection of isotopically labeled proteins, produced in bacteria, into the cytosol 12 . In this system, protein phosphorylation and structures of nucleic acids have been investigated [15] [16] [17] [18] . Alternatively, the isotopically labeled proteins can be delivered into the eukaryotic cytoplasm via CPPs (cellpenetrating peptides) covalently linked to the protein. The proteins are subsequently released from CPPs by endogenous enzymatic action or by autonomous reductive cleavage 3 . Ogino et al. 13 exploited the pore-forming toxin streptolysin O to import the protein thymosin β4 into human cells. One advantage of this approach, in contrast to the CPP strategy, is that no modifications to the protein are required for intracellular sample delivery 19 . Recently, protein electroporation has been developed; this approach involves applying an electric pulse to cells to insert the purified protein of interest into the cytosol 10, 14 .
All these methods rely on heterologous protein expression and purification and subsequent insertion of the protein into the cell. This implies that several aspects cannot be easily addressed, such as the steps of protein maturation, including folding, cofactor binding, cysteine oxidation and so on, as the proteins expressed and purified from bacterial cells are already folded/oxidized and usually need additional treatment before insertion, which makes it harder to obtain meaningful information from in-cell NMR data. Therefore, a strategy for producing, labeling and studying proteins directly in eukaryotic cells is desirable. Intracellular expression strategies for in-cell NMR have been successfully applied to yeast and insect cells 20, 21 . Such approaches would be especially suited for proteins that (i) have a tendency to aggregate in vitro at high concentrations; (ii) undergo cotranslational processes for correct folding or intracellular targeting; and (iii) are sensitive to the redox properties of the environment (e.g., require thiol-based reducing agents and/or the absence of oxygen). Furthermore, human proteins should be investigated in a human cellular environment, to closely match the physiological conditions in terms of molecular composition.
Here we describe a step-by-step procedure for the preparation of samples of HEK293T cells expressing isotopically labeled proteins, and for the recording of in-cell NMR experiments. This protocol relies on transiently transfecting the cells with one or more genes of interest using a vector designed for high-level constitutive cytoplasmic protein expression. Isotope labeling is achieved through the use of a growth medium isotopically labeled at the time of transfection. Cotransfection of two or more genes can be performed, resulting in simultaneous expression and labeling of the proteins. After protein expression, in-cell NMR data are collected to obtain information on the intracellular conformation of the protein(s). Compared with the protein-insertion strategies, intracellular expression has the advantage of providing higher physiological relevance, especially when applied to study processes that are highly dependent on the chemical environment, whereas a disadvantage is the nonspecific isotopic enrichment during protein expression, which causes cellular background signals to be detected together with the protein of interest, requiring further data processing.
Despite the general limitation of in-cell solution NMR, which cannot detect globular proteins if they interact with large cellular components (see Troubleshooting of Step 34) , this protocol should be applicable to a broad range of soluble cytoplasmic proteins, and it can be adapted to proteins localized in different cellular compartments.
Applications
The protocol for protein overexpression in human HEK293T cells for in-cell NMR studies has been successfully applied to a number of systems 5, [22] [23] [24] [25] [26] [27] . Several functional processes, including metal uptake 5, 24 , disulfide-bond formation 5, 22, 24, 26 and protein folding 22, 26 , have been characterized for different proteins with different features and behaviors, and in different cellular compartments 23 . For superoxide dismutase 1 (SOD1) and for a number of its familial amyotrophic lateral sclerosis (fALS)-linked mutants, the post-translational modifications occurring after the protein synthesis have been studied via analysis of the protein state as a function of the growth conditions 5, 24 . The maturation process of SOD1 involves zinc binding, homodimer formation, copper uptake and oxidation of the intrasubunit disulfide bond. By treating the cells differently during protein expression, one can observe the various protein conformations, from the immature, metal-free form to the various metalated and/or oxidized forms to the final mature protein 5 .
In cells grown without metal ion supplements, essentially only the monomeric, metal-free, reduced SOD1 (apo-SOD1) is present. The addition of Zn 2+ to the culture medium eliminates the apo-SOD1 species, and only the dimeric species with one Zn 2+ ion bound to each subunit (E,Zn-SOD1) is formed. Therefore, Zn 2+ ions are efficiently taken up by cells in culture and bind specifically to the native binding site of dimeric SOD1 in stoichiometric amounts. Copper incorporation of SOD1 in eukaryotes is known to be dependent on the protein CCS. When both proteins are overexpressed, the SOD1 intrasubunit disulfide bond is partially oxidized. When cells, after overexpression of both SOD1 and CCS, are incubated with Cu(II), almost all of the SOD1 is in the Cu(I),Zn-bound form, at variance with cell samples with a basal CCS level. Moreover, the intrasubunit disulfide bridge of SOD1 is completely oxidized. This behavior indicates that in vivo CCS has a role in promoting both copper incorporation in SOD1 and disulfide bond formation 28 .
The SOD1 maturation pathway has also been investigated for a series of fALS-linked SOD1 mutants, and those studies showed that, for a subset of mutants, impaired zinc binding triggers the accumulation of an unstructured species in the cytoplasm 24 . Coexpression of CCS prevented SOD1 misfolding, and it restored the correct maturation pathway. This application highlights the advantage of intracellular protein expression over the proteindelivery approaches. In the apo state, these SOD1 mutants are intrinsically destabilized, are prone to misfolding and aggregation in vitro and cannot reach the high concentration needed for efficient intracellular delivery. Therefore, the approach described here is especially valuable for studying protein misfolding events, which are difficult to control in vitro.
We have also characterized the folding and redox properties of Mia40, which is an oxidoreductase involved in the mitochondrial protein-import process 22 . The in-cell NMR spectra revealed that Mia40 in the cytoplasm is present mostly in a folded state, which is not competent for mitochondrial import. The dependence of Mia40 redox and folding state on the overexpression of glutaredoxin 1 (Grx1) and thioredoxin 1 (Trx1) has also been investigated 22 . The amount of intracellular folded Mia40 decreased when either Grx1 or Trx1 was coexpressed, showing that both thiol-disulfide-regulating proteins affect the Mia40 redox state. Grx1 keeps Mia40 reduced more effectively than Trx1 does, suggesting that the two proteins differentially regulate the mitochondrial import of Mia40.
Experimental design
Although this protocol was optimized on HEK293T cells, in principle protein expression at sufficient levels can be obtained in other mammalian cell lines. However, some steps will probably have to be modified. Specifically, the transfection method and the choice of promoter for constitutive gene expression should be optimized for each cell line. As a rule of thumb, cells that have been used successfully as protein-expression systems (e.g., HEK293T (ref. 29 ) cells, Chinese hamster ovary 30 cells and simian-derived COS cells 31 ) should be able to reach high transfection efficiency and sufficient protein levels for in-cell NMR experiments.
The genes of interest need to be cloned in a vector that is suitable for high-level constitutive protein expression in mammalian cells. In this protocol, the pHLsec plasmid is used 29, 32 . The gene of interest is transcribed by a CAG promoter, which is very active in HEK293T cells, and it allows high protein levels to be reached. The pHLsec vector is designed for expressing secreted proteins; however, the secretion sequence can be removed during the cloning, allowing the native proteins to be expressed in the cytoplasm 5 . To ensure successful transfection and protein expression, the transfected DNA has to be endotoxin free, as bacterial endotoxins induce inflammatory reactions of the mammalian immune system. Usually, endotoxin-free Midi and Maxi DNA preparations are preferred, as they provide enough DNA for ~15 and ~30 in-cell NMR samples, respectively. The DNA is transfected as a complex with the cationic polymer PEI, which ensures high transfection efficiency and a high copy number per cell 29 .
For each protein, the optimal expression conditions (in terms of time and amount of DNA) may have to be screened, either by Coomassie-stained SDS−PAGE or by western blotting of the cell lysates. Usually, the highest expression levels are reached between 48 and 72 h after transfection. It is possible to coexpress two proteins simultaneously by mixing the two DNAs in the transfection procedure. Optimal coexpression conditions have to be screened by varying the amount of DNA of each construct. If desired, the protein expression level can be decreased by dilution of the DNA encoding the protein of interest with an empty DNA vector (the total amount of DNA is kept constant). The screening can be done on scaled-down cultures (e.g., in T25 flasks or six-well dishes). For quantification of the expression levels, the lysates obtained for each condition are run on a reducing SDS-PAGE together with protocol nature protocols | VOL.11 NO.6 | 2016 | 1103 serial dilutions of a purified protein sample at known concentration, which provides a calibration curve. Each sample should be loaded at different dilutions for better quantification. Protein detection can be performed by densitometry analysis on the Coomassie-stained gel. Alternatively, especially for lower expression levels, the proteins can be detected by western blotting and densitometry analysis.
Some applications may require the addition of additional reagents to the cell culture at some point during the sample preparation. As an example, some proteins need cofactors in order to fold properly and/or to reach the functional state. Such cofactors can be either small molecules or metal ions. To avoid cellular toxicity or decreased protein expression, the optimal concentration of cofactor(s) and timing of the addition(s) should be tested. For example, copper ions are toxic at high concentration and inhibit protein expression, so they have to be added at a later stage after protein expression. Other transition metals, such as zinc, do not seem to affect protein expression and can be added at the time of transfection. Protein expression and cell viability can be checked by western blotting and Trypan Blue staining, respectively, whereas the effects on the protein folding/functional state can be observed by NMR experiments on intact cells or lysates.
A prerequisite for heteronuclear NMR experiments is that NMR-active isotopes ( 13 C and 15 N) must be incorporated into the overexpressed proteins. For this purpose, the growth medium needs to be replaced at the time of transfection with a medium that is isotopically labeled. Labeled media suitable for mammalian cell growth are commercially available (Bioexpress 6000, CIL) and cost ~5,500 USD/liter (U-15 N) or 11,000 USD/liter (U-13 C, 15 N). This initial cost is high, but in our protocol only 20 ml of labeled medium is required to obtain one in-cell NMR sample, resulting in a per-sample cost of 110 USD ( 15 N) or 220 USD ( 13 C, 15 N). In most cases, the labeled medium can be recovered after protein expression, centrifuged to remove cell debris and residual DNA: PEI complex, and used again to prepare a second cell sample, which further reduces the cost per sample. For some applications, typically when some protein signals fall in a spectral region that is free from cellular background (for example, histidine ring N-1 H protons 5, 24 ; isolated 1 H signals arising from the protein hydrophobic core 22, 27 ), unlabeled samples can be prepared for 1 H-only in-cell NMR experiments, resulting in the cost per sample being greatly reduced. One can also use amino-acid-selective labeling schemes, by preparing a homemade cell growth medium following the composition of the commercial unlabeled medium and adding the isotopically labeled amino acid(s) according to the desired labeling scheme. During protein expression, the amount of serum is reduced to 2% (vol/vol), to prevent excessive isotopic dilution and to minimize nonspecific isotopic incorporation, by decreasing the cell growth rate 32, 33 .
In our protocol, 3-mm Shigemi NMR tubes are used to minimize the amount of cells needed and to cut the sample-preparation costs. On average, an NMR sample obtained from one confluent T75 flask (75 cm 2 ) contains 3.5 × 10 7 ± 1.1 × 10 7 cells, which occupy 130 ± 30 µl when spun down; this is enough to fill the tube section corresponding to the active volume of the NMR instrument. The resulting pellet contains ~50% (vol/vol) cells (average cell volume of 2 pl). 3-mm Shigemi tubes can be used in 5-mm probes with a proper spinner/adaptor. If more cells are available, larger tubes (5 mm normal/Shigemi tubes) may be used to increase the signalto-noise ratio (S/N) of the experiments, as shown elsewhere 34, 35 .
After the cells have been detached from the culture flask, the in-cell NMR experiments should be performed as quickly as possible to minimize cell death. To overcome the intrinsic low sensitivity of NMR, some pulse sequences have been optimally designed to maximize the S/N per unit time. For example, 1 H-15 N SOFAST-HMQC experiments are preferred instead of the classical heteronuclear single quantum coherence (HSQC) variants. Usually, >90% of HEK293T cells are still viable after 2-2.5 h at 37 °C, which is longer than the time needed to collect one SOFAST-HMQC spectrum (1 h) plus several 1D 1 H NMR spectra. Longer experimental times result in cell death because of O 2 and/or nutrient depletion and the build-up of acidic metabolic products. For these reasons, NMR experiments should be planned and set up in advance whenever possible.
MaterIals

REAGENTS
Cell line of interest. This procedure has been optimized for the HEK293T cell line (ATCC CRL-3216) ! cautIon The cell lines used should be regularly checked to ensure that they are authentic and that they are not infected with mycoplasma. pHLsec plasmid 29 
2| Wash the cells twice with 7 ml of PBS (each wash).
3| Add 2 ml of trypsin/EDTA, and incubate it for 2 min at room temperature (25 °C) to detach the cells.
4|
Inactivate trypsin with 20 ml of complete DMEM.
5|
Centrifuge the cells at 800g for 5 min at room temperature, and discard the supernatant.
6|
Resuspend the cell pellet in 10 ml of complete DMEM, carefully breaking up any clumps of cells.
7|
If you are transfecting the cells on day 2, for each in-cell NMR sample inoculate 2.2 ml of cell suspension in a new T75 flask, and add 20 ml of complete DMEM. Alternatively, the DNA transfection can be performed on day 3. If that is the case, inoculate 1 ml of cell suspension per in-cell NMR sample. See Figure 1 for the alternative timing.
8|
Place the inoculated flasks at 37 °C in a humidified atmosphere containing 5% CO 2 .
transient transfection with the gene(s) of interest or empty vector (day 2)
• tIMInG 30 min 9| To 2.5 ml of medium (depending on the chosen labeling scheme, use either DMEM, 15 N-labeled medium or homemade medium with specific labeled amino acids) without serum, add 25 µg of endotoxin-free DNA.
10|
To 2.5 ml of medium without serum (the same as in Step 9), add 50 µg of PEI.
11|
Slowly add the PEI solution to the DNA solution.  crItIcal step To ensure proper transfection efficiency, add PEI to DNA, not vice versa. Do not shake the tube.
12|
Wait for 20 min to allow the formation of the DNA-PEI complex.
13| Discard the old medium from the T75 flask and carefully eliminate any trace of medium.
14|
Add the DNA-PEI mixture to the cells and subsequently add 15 ml of the same medium as in Step 9 supplemented with 2% (vol/vol) FBS and antibiotics. Nontoxic cofactors/metal ions can be added to the expression medium during this step. If toxic compounds/metal ions are required, they should be added after protein expression but before cell collection. 
15|
Place the flask at 37 °C in a humidified atmosphere containing 5% CO 2 . Carry on protein expression for 2 or 3 d (see Fig. 1 ).
setup of the nMr experiments (day 4)
• tIMInG 1 h 16| Set the experimental temperature at the NMR spectrometer. Typically, the temperature is set to 310 K, which is close to the physiological temperature; this provides 2-3 h of sample stability. Lower temperatures may increase the sample stability, but they usually cause noticeable line broadening, because of the increased viscosity of the environment.
17|
Prepare an empty data set at the NMR spectrometer, and set the parameters for each NMR experiment by following options A and B. This step should be performed at any time before the preparation of the in-cell NMR sample, to minimize the delay between cell collection and data acquisition. There are several variants of NMR experiments that are suitable for short-lived samples such as living HEK293T cells in an NMR tube. Here we describe those that are most commonly used in the reported applications of this protocol. Typically, samples are first analyzed with a 1D 1 H NMR experiment with excitation sculpting for water suppression (Bruker zgesgp pulse program) 36 (option A). In the case that a sizable number of 1 H resonances of the protein of interest fall in regions of the 1 H spectrum free of signals from the cellular background (i.e., >10 p.p.m. or <0.5 p.p.m.), analysis by 1 H NMR on unlabeled cell samples can be performed. In such cases, a 1D 1 H NMR WATERGATE experiment with a 3-9-19 binomial pulse train for water suppression provides good sensitivity (Bruker p3919gp pulse program) 37 .
With 15 N-labeled samples, after the acquisition of a 1D 1 H NMR spectrum, a 1 H-15 N SOFAST-HMQC NMR experiment (Bruker sfhmqcf3gpph pulse program) 38 is acquired (option B), which will be the major source of structural information. The SOFAST-HMQC sequence relies on band-selective shaped pulses for 1 H excitation and refocusing. Both the pulse length and the offset frequency can be adjusted depending on the desired 1 H excitation region. In our standard setup, the pulse lengths and offset are calculated for the amide region of folded proteins. The inter-scan delay can be optimized, within the safe operating limits of the instrument, through measurement of the obtained S/N per unit time at different delays. Optionally, nonuniform sampling schemes can be used, either to reduce the acquisition time for each experiment (provided the S/N is high enough) or to improve the resolution along the 15 Different timings for cell transfection and protein expression can be planned to fit the experimental needs and the NMR instrument schedule. Transfection can be performed either at day 2 or at day 3 after cell seeding at day 1. For transfection at day 2, seed 2.2 ml out of 10 ml of cell suspension (from a confluent T75 flask); for transfection at day 3, seed 1 ml out of 10 ml of cell suspension. The NMR sample will be prepared on different days, according to the planned protein expression time. 
22|
23| Wash the cells with 10 ml of PBS to remove the residual medium.
24|
25|
Transfer the cells to a 1.5-ml capped tube.
26|
Resuspend the cell pellet in 180 µl of NMR buffer (DMEM supplemented with 70 mM HEPES, 90 mM glucose, 20% (vol/vol) D 2 O). This formulation was optimized for increased buffering capacity and to compensate for the faster glucose consumption, because of the high cell density in the NMR tube.  crItIcal step DMEM is buffered by CO 2 /HCO 3 − . To avoid the formation of CO 2 bubbles in the NMR tube, after HEPES addition, remove the CO 2 by bubbling air for 10 min.
27| Take 10 µl of the cell suspension for measuring the cell viability before the NMR experiments by Trypan Blue staining (Steps 45-48). The aliquot can be stored on ice for 1-2 h.
28|
With a long glass pipette, transfer the cell suspension to the bottom of a 3-mm Shigemi NMR tube; do not use the inner plunger, and close the tube with a standard 3-mm cap.
29|
Allow the cells to settle at the bottom of the tube. You can increase the speed of this step by slowly spinning the tube with a hand-operated centrifuge for ~3 min. Do not remove the supernatant. acquisition of the nMr spectra • tIMInG 1-3 h 30| Load a data set with the desired NMR experiments (see Step 17) .
31|
Insert the in-cell NMR sample into the magnet, check the tuning of the probe head and shim the magnet.  crItIcal step In our experience, the automated shimming procedure of modern Bruker instruments (the 'topshim' routine) applied on the cell samples yields results as good as those obtained on the same Shigemi tube filled with aqueous buffer and the inner plunger. In practice, any residual field inhomogeneity seems not to be critical compared with the signal broadening caused by the protein of interest being inside the cells. Water suppression could pose some issues for poorly shimmed samples. However, one can optimize SOFAST-HMQC spectra for such samples by moving the 1 H excitation window (i.e., the offset frequency of the band-selective 1 H shaped pulses) farther away from the water signal.
32|
Calibrate the 1 H 90° hard pulse length.
33|
Adjust the 1 H power levels in each pulse sequence according to the 1 H hard pulse.
34|
Acquire the NMR spectra. Process the data as described in Box 1 (Fig. 2) . Quick processing can be performed to check the outcome of the experiment; the background subtraction can be performed at a later stage. /(B + W) . Ideally, cell viability should remain higher than 90% after the NMR experiments.
Box 1 | Processing of the 2D NMR experiments
Typically, 2D 1 H-15 N NMR spectra are processed via multiplication of both dimensions by a square sine bell function (90° shift), zero-filled and Fourier-transformed in both dimensions. In some cases, amide resonances arising from the in-cell NMR sample will relax faster than the acquisition time (in one or both spectral dimensions). In such cases, decreasing the number of effective data points used in the Fourier transform, before zero-filling, can improve the spectra. As this choice can be made during the processing step, it is suggested to always acquire the NMR spectra with the highest possible number of points in both dimensions (compatibly with the experimental time and with the safety limits for decoupling during acquisition), in order to maximize the spectral resolution for slow-relaxing signals. If needed, some points can be discarded later.
In the case of isotopically labeled cell samples, during protein expression the NMR-active isotope(s) will also be incorporated into all the other molecules of the cells. Therefore, 15 N-labeled cell samples give rise to background amide signals in the 2D NMR spectra, originating mostly from other proteins and abundant peptides, such as glutathione. These background signals can be greatly reduced in the 2D NMR spectra by the subtraction of two Fourier-transformed spectra: one acquired on the in-cell NMR sample containing the protein(s) of interest, and the other acquired on a control in-cell NMR sample, prepared in exactly the same conditions as the previous but with the cells transfected with the empty DNA vector (Fig. 2) . The two experiments need to be set up and processed using identical parameters (except for the power levels of the shaped pulses, which should be adjusted according to the 1 H hard pulse length). Therefore, it is advisable to plan the set of 2D NMR experiments always combined with a control in-cell NMR spectrum. All these spectra should be collected with identical experimental parameters such as temperature, spectral width, number of increments and shape pulse profiles. Thus, a single control in-cell NMR sample can be used for processing different in-cell NMR experiments, provided that the cell culture conditions and experimental setup have not changed during the collection of the various experiments. ? trouBlesHootInG Troubleshooting advice can be found in table 1.
• tIMInG Fig. 1 ) 22, 25 Lyse the cells and acquire the same NMR spectra on the cleared cell lysate. If the protein is clearly detected in the cell lysate but not in the cells, it is likely that transient interactions with large intracellular molecules have occurred. In such cases, a mutational strategy may be followed to selectively disrupt transient interactions. This approach has been proven to be successful in making human profilin 1 detectable by in-cell solution NMR 25 
38
The protein NMR signals are detected in the supernatant
The protein has leaked from the cells. This is likely a consequence of high cell mortality, which can be assessed with the Trypan Blue test
Try to be as quick as possible in the preparation of the NMR sample by reducing the dead times in the procedure.
Reduce the acquisition time of the NMR experiments
The overexpressed protein might be produced at levels that are toxic to the cells A number of proteins among those that we tested reached expression levels suitable for observation by incell NMR: SOD1 (both wild-type and fALS-related mutants), CCS, HAH1, Mia40, Cox17, profilin 1 (with surface mutations), Grx1 and Trx1 (Fig. 3a) . The highest expression levels obtainable varied among proteins, ranging from ~150 (for SOD1) to ~10 µM (for Cox17), as measured from either Coomassie-stained SDS-PAGE or western blot (Fig. 3b,c and supplementary  Fig. 2) . Decreasing the amount of DNA added in the transfection step will reduce the expression levels, making it possible to approach physiological concentrations, when levels are compatible with NMR detectability (Fig. 3d) . The expression levels obtained in each condition are very reproducible, falling within 5% (s.d.) from the average as calculated over several samples, which were identically prepared in different years. Most of the proteins reported here can be clearly detected in in-cell 1 H-15 N SOFAST-HMQC NMR spectra recorded on uniformly 15 N-labeled cell samples (Fig. 4a-f) . These 1 H-15 N in-cell NMR spectra contain residue-level information about protein conformational properties, and they can be compared with the spectra acquired on the same proteins in vitro ( Fig. 4g-l) to better characterize the intracellular species. With this approach, different metallation states of SOD1 are easily identified; for example, apo-SOD1, which is a partially disordered monomer, is readily converted to E,Zn-SOD1 (a well-folded homodimer) when cells are treated with zinc (Fig. 5a) . Amino-acid-selective labeling can be achieved through the use of homemade expression media supplemented with the desired labeled amino acid(s). For example, spectra can be obtained for samples grown with either [ 15 N]cysteine (Fig. 5b) or [ 13 C-methyl]methionine (Fig. 5c) . The labeling efficiency when using [ 15 N]cysteine homemade media was estimated from cross-peak intensities as 75% ± 10% (s.d., calculated on four cysteine signals) of the efficiency obtained in the commercial [U-15 N] medium, whereas the intensity of the background signals was much lower (compare Figs. 2a and 5b) . Other aminoacid-selective labeling schemes can be achieved in principle; however, the amount of spurious isotopic incorporation is expected to vary with the nature of the amino acid. The [ 15 N]cysteine labeling is especially useful for investigating the redox state of the protein of interest, whenever the formation of disulfide bonds affects the amide chemical shifts of the involved cysteines. Indeed, the 1 H-15 N SOFAST-HMQC spectra acquired on HEK293T cells expressing [ 15 N]cysteine-labeled SOD1 showed that Cys146, which forms an intrasubunit disulfide bond with Cys57 in the mature enzyme, was reduced (Fig. 5b) . The methionine labeling has the advantage of being relatively inexpensive, and it allows the investigation of slow-tumbling macromolecules because of the favorably slower relaxation of the CH 3 moiety 39 (Fig. 5c) 
